Subscribe

Spotlight -

This Year In Medicine 2025

Management of Beta Thalassemia

Episodes

Specialty:

All

Year:

All

EP. 1: Overview of Beta Thalassemia

January 31st 2020

EP. 2: Prevalence and Clinical Presentation of Beta Thalassemia

January 31st 2020

EP. 3: Beta Thalassemia Severity and Impact on Patients' Quality of Life

January 31st 2020

EP. 4: Impact of Beta Thalassemia on the Providers

January 31st 2020

EP. 5: Current Approaches for Beta Thalassemia

January 31st 2020

EP. 6: The Role of Transfusion for Beta Thalassemia

January 31st 2020

EP. 7: Understanding Transfusion for Beta Thalassemia

January 31st 2020

EP. 8: Iron Dysregulation & Allogeneic Stem Cell Transplantation

January 31st 2020

EP. 9: Approval of Novel Therapy for Beta-Thalassemia

January 31st 2020

EP. 10: End Points of Phase III Study for Beta-Thalassemia

January 31st 2020

EP. 11: Future Impact of the Novel Therapy for Beta-Thalassemia

January 31st 2020

EP. 12: The Potential for Gene Therapy in Beta-Thalassemia

January 31st 2020

EP. 13: The Process for Gene Therapy in Beta-Thalassemia

January 31st 2020

EP. 14: The Cost and Safety of Gene Therapy in Beta-Thalassemia

January 31st 2020

EP. 15: Pipeline Agents for the Treatment of Beta-Thalassemia

January 31st 2020

EP. 16: Final Thoughts on the Treatment of Beta-Thalassemia

January 31st 2020

Trending on HCPLive

Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap

GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF

ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans

Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial

Ralinepag Improves Clinical Outcomes in Contemporary PAH Population